Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares were up 1.8% during mid-day trading on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The stock’s 50 day moving average is C$0.58 and its two-hundred day moving average is C$0.58. The company has a debt-to-equity ratio of 0.52, a current ratio of 9.74 and a quick ratio of 9.41. The firm has a market cap of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- Why is the Ex-Dividend Date Significant to Investors?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- 3 Stocks to Consider Buying in October
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
